Food Package Labeling – Americans Want Nutrition Labels

MLT CreativeIndustries

According to recent food package labeling news reports, 84% of those surveyed in a Reuters/Ipsos opinion poll believe the U.S. government should require food packaging have nutrition labels – even those who essentially ignore the labels. Under the Trump administration, the introduction of mandatory labeling of genetically engineered ingredients use and added sugars in packaged foods has been delayed by …

Pharma Marking – Ocaliva Incorrect Dosage Warning Issued By The FDA

MLT CreativeNews

Ocaliva (obeticholic acid) is a drug manufactured by Intercept Pharmaceuticals for treatment of PBC or primary biliary cholangitis, a rare and chronic disease of the liver that damages the organ as a result of the bile build-up that occurs when the bile ducts become damaged, inflamed, or are destroyed. Now, the FDA has issued a warning regarding excessive dosing of …

Food Packaging – If Recycling Isn’t An Option, Is Biodegradability Plan B?

MLT CreativeIndustries

A recent study found that, when recycling of food packaging isn’t an option, consumers were interested in whether packaging is biodegradable. For 43% of consumers, including information on packaging about how to recycle was important. About a third of consumers felt that labels should include information regarding sustainability credentials and the product’s carbon footprint. Asia Pulp and Paper conducted an …

Pharma Coders – Teva Pharmaceutical’s New President And CEO

MLT CreativeIndustries

On Monday September 11, it was announced that Teva Pharmaceutical Industries, the largest maker of generic drugs in the world, had a new President and CEO – 30-year pharmaceutical and health care veteran, Kare Schultz, previously COO at Novo Nordisk and currently CEO and President at H. Lundbeck A/S in Denmark. In February, Teva CEO, Erez Vigodman, left his position …

Pharma Coding – Novartis’ Kymriah Approved By FDA

MLT CreativeIndustries

On August 30th, Novartis’ Kymriah was approved by the U.S. Food & Drug Administration for treating a form of ALL (acute lymphoblastic leukemia) in individuals age 25 and younger. Kymriah, or tisagenlecleucel is a CAR-T (Chimeric Antigen Receptor T-Cell) therapy that, according to reports, is a one-time treatment. The treatment is customized to each patient, as his or her T-cells …